Aegerion Pharmaceuticals, Inc (NASDAQ:AEGR) CEO Marc D. Beer purchased 10,000 shares of Aegerion Pharmaceuticals stock on the open market in a transaction dated Tuesday, May 27th. The stock was purchased at an average price of $31.59 per share, with a total value of $315,900.00. Following the completion of the acquisition, the chief executive officer now directly owns 59,400 shares in the company, valued at approximately $1,876,446. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) net profit margin is -82.20% and weekly performance is 2.20%. On last trading day company shares ended up $33.04. Analysts mean target price for the company is $71.36. Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR) distance from 50-day simple moving average (SMA50) is -16.34%.
Seattle Genetics Inc (NASDAQ:SGEN) Director Felix Baker purchased 281,963 shares of Seattle Genetics stock in a transaction dated Wednesday, June 4th. The shares were purchased at an average price of $34.86 per share, with a total value of $9,829,230.18. Following the transaction, the director now directly owns 76,997 shares in the company, valued at approximately $2,684,115. Seattle Genetics, Inc. (NASDAQ:SGEN) shares advanced 2.51% in last trading session and ended the day on $36.41 . Gross Margin is 91.70% and its return on assets is -13.10%. Seattle Genetics, Inc. (NASDAQ:SGEN) quarterly performance is -31.78%.
Coronado Biosciences Inc (NASDAQ:CNDO) CFO Lucy Lu bought 5,000 shares of Coronado Biosciences Inc stock in a transaction dated Monday, June 2nd . The shares were purchased at an average price of $ 1.37 per share, with a total value of $ 6,850.00. Coronado Biosciences Inc (NASDAQ:CNDO) shares moved down -1.19% in last trading session and was closed at $1.66, while trading in range of $1.64 – $1.70. Coronado Biosciences Inc (NASDAQ:CNDO) year to date (YTD) performance is -36.88%.
OvaScience Inc (NASDAQ:OVAS) Director Richard Aldrich bought 2,000 shares of OvaScience Inc stock in a transaction dated Monday, June 2nd. The shares were purchased at an average price of $ 7.29 per share, with a total value of $ 14,580.00. OvaScience Inc (NASDAQ:OVAS) ended the last trading day at $7.26. Company weekly volatility is calculated as 6.35% and price to cash ratio as 1.97. OvaScience Inc (NASDAQ:OVAS) showed a negative weekly performance of -2.16%.
ImmuCell Corporation (NASDAQ:ICCC) David Cunningham bought 1,500 shares of ImmuCell Corporation stock in a transaction dated Tuesday, May 15th. The shares were purchased at an average price of $ 3.91 per share, with a total value of $ 5,865.00. ImmuCell Corporation (NASDAQ:ICCC) net profit margin is 1.60% and weekly performance is -6.02%. On last trading day company shares ended up $4.14. ImmuCell Corporation (NASDAQ:ICCC) distance from 50-day simple moving average (SMA50) is -2.19%.